These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

54 related items for PubMed ID: 2434743

  • 1. Wy-46,300 and Wy-46,531: vascular smooth muscle relaxant/antihypertensive agents with combined Ca2+ antagonist/myosin phosphorylation inhibitory mechanisms.
    Silver PJ, Sulkowski TS, Lappe RW, Wendt RL.
    J Cardiovasc Pharmacol; 1986; 8(6):1168-75. PubMed ID: 2434743
    [Abstract] [Full Text] [Related]

  • 2. Structural variants of verapamil and W-7 with combined Ca2+ entry blockade/myosin phosphorylation inhibitory mechanisms.
    Silver PJ, Fenichel R, Wendt RL.
    J Cardiovasc Pharmacol; 1988 Mar; 11(3):299-307. PubMed ID: 2452922
    [Abstract] [Full Text] [Related]

  • 3. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB, Giardino EC, Salata JJ, Moore JB, Falotico R.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [Abstract] [Full Text] [Related]

  • 4. Thyroid hormones directly interact with vascular smooth muscle strips.
    Ishikawa T, Chijiwa T, Hagiwara M, Mamiya S, Hidaka H.
    Mol Pharmacol; 1989 Jun; 35(6):760-5. PubMed ID: 2733694
    [Abstract] [Full Text] [Related]

  • 5. Effects of calcium antagonists and vasodilators on arterial myosin phosphorylation and actin-myosin interactions.
    Silver PJ, Dachiw J, Ambrose JM.
    J Pharmacol Exp Ther; 1984 Jul; 230(1):141-8. PubMed ID: 6747823
    [Abstract] [Full Text] [Related]

  • 6. Effects of felodipine, nitrendipine and W-7 on arterial myosin phosphorylation, actin-myosin interactions and contraction.
    Silver PJ, Ambrose JM, Michalak RJ, Dachiw J.
    Eur J Pharmacol; 1984 Jul 20; 102(3-4):417-24. PubMed ID: 6489434
    [Abstract] [Full Text] [Related]

  • 7. Regulation of contractile activity in vascular smooth muscle by protein kinases.
    Silver PJ.
    Rev Clin Basic Pharm; 1985 Jul 20; 5(3-4):341-95. PubMed ID: 3029813
    [Abstract] [Full Text] [Related]

  • 8. Antihypertensive and vasorelaxant activities of Laelia autumnalis are mainly through calcium channel blockade.
    Vergara-Galicia J, Ortiz-Andrade R, Castillo-España P, Ibarra-Barajas M, Gallardo-Ortiz I, Villalobos-Molina R, Estrada-Soto S.
    Vascul Pharmacol; 2008 Jul 20; 49(1):26-31. PubMed ID: 18534917
    [Abstract] [Full Text] [Related]

  • 9. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M, Koibuchi Y, Sakai S, Tsujioka K, Fujiwara T, Ozaki T, Maeda K, Motoyama I, Horiai H, Ono T.
    Arzneimittelforschung; 1988 Nov 20; 38(11):1605-18. PubMed ID: 3214444
    [Abstract] [Full Text] [Related]

  • 10. Calcium channel blockade in vascular smooth muscle cells: major hypotensive mechanism of S-petasin, a hypotensive sesquiterpene from Petasites formosanus.
    Wang GJ, Shum AY, Lin YL, Liao JF, Wu XC, Ren J, Chen CF.
    J Pharmacol Exp Ther; 2001 Apr 20; 297(1):240-6. PubMed ID: 11259550
    [Abstract] [Full Text] [Related]

  • 11. Quinine inhibits vascular contraction independent of effects on calcium or myosin phosphorylation.
    Adegunloye B, Lamarre E, Moreland RS.
    J Pharmacol Exp Ther; 2003 Jan 20; 304(1):294-300. PubMed ID: 12490604
    [Abstract] [Full Text] [Related]

  • 12. Effects of the calmodulin antagonist, fluphenazine, on phosphorylation of myosin and phosphorylase in intact smooth muscle.
    Silver PJ, Stull JT.
    Mol Pharmacol; 1983 May 20; 23(3):665-70. PubMed ID: 6688120
    [Abstract] [Full Text] [Related]

  • 13. Effects of the calcium antagonists perhexiline and cinnarizine on vascular and cardiac contractile protein function.
    Silver PJ, Dachiw J, Ambrose JM, Pinto PB.
    J Pharmacol Exp Ther; 1985 Sep 20; 234(3):629-35. PubMed ID: 3162016
    [Abstract] [Full Text] [Related]

  • 14. Antiproliferative action of an angiotensin I-converting enzyme inhibitory peptide, Val-Tyr, via an L-type Ca2+ channel inhibition in cultured vascular smooth muscle cells.
    Toshiro M, Ueno T, Tanaka M, Oka H, Miyamotq T, Osajima K, Matsumoto K.
    Hypertens Res; 2005 Jun 20; 28(6):545-52. PubMed ID: 16231761
    [Abstract] [Full Text] [Related]

  • 15. Possible mechanisms underlying the midazolam-induced relaxation of the noradrenaline-contraction in rabbit mesenteric resistance artery.
    Shiraishi Y, Ohashi M, Kanmura Y, Yamaguchi S, Yoshimura N, Itoh T.
    Br J Pharmacol; 1997 Jul 20; 121(6):1155-63. PubMed ID: 9249252
    [Abstract] [Full Text] [Related]

  • 16. Effects of adrenomedullin and calcitonin gene-related peptide on contractions of the rat aorta and porcine coronary artery.
    Yoshimoto R, Mitsui-Saito M, Ozaki H, Karaki H.
    Br J Pharmacol; 1998 Apr 20; 123(8):1645-54. PubMed ID: 9605572
    [Abstract] [Full Text] [Related]

  • 17. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries.
    Kanda M, Shirahase H, Kurahashi K, Wada K, Nakamura S, Matsui H, Fukata F.
    Arzneimittelforschung; 1995 Aug 20; 45(8):831-5. PubMed ID: 7575741
    [Abstract] [Full Text] [Related]

  • 18. Acute and chronic captopril, but not prazosin or nifedipine, normalize alterations in adrenergic intracellular Ca2+ handling observed in the mesenteric arterial tree of spontaneously hypertensive rats.
    Miquel R, Gisbert R, Serna E, Perez-Vizcaino F, Anselmi E, Noguera MA, Ivorra MD, D'Ocon MP.
    J Pharmacol Exp Ther; 2005 Apr 20; 313(1):359-67. PubMed ID: 15615866
    [Abstract] [Full Text] [Related]

  • 19. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
    Yamaura T, Kase N, Kita H, Uematsu T.
    Arzneimittelforschung; 1986 Apr 20; 36(1):29-34. PubMed ID: 3754142
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L, Angelico P, Ibba M, Poggesi E, Taddei C, Leonardi A, Testa R.
    Arzneimittelforschung; 1996 Jan 20; 46(1):15-24. PubMed ID: 8821512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.